Literature DB >> 3135884

Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain.

J I Mann1, B Lewis, J Shepherd, A F Winder, S Fenster, L Rose, B Morgan.   

Abstract

To establish the distribution of blood lipid concentrations and the prevalences of other risk factors for cardiovascular disease in Britain 12,092 men and women aged 25-59 in Glasgow, Leicester, London, and Oxford were studied. Subjects were selected by opportunistic case finding, in which patients consulting their general practitioner for any reason were offered a health check by appointment, or random selection from age-sex registers, in which an invitation for a health check was posted. The overall rate of response was 73%, being 91-94% by opportunistic case finding and 36-63% by random selection. At the health check subjects answered a brief questionnaire about risk factors for cardiovascular disease, and their height, weight, and blood pressure were recorded; a blood sample was taken for measuring plasma concentrations of cholesterol, triglyceride, high density lipoprotein cholesterol, and glucose. The mean cholesterol concentrations were 5.9 (SD 1.2) and 5.8 (1.2) mmol/l in men and women, respectively. In London the mean value was 5.5 (1.2) mmol/l for both men and women and was significantly lower than mean values in the three other centres, among which there were no significant differences. In men and women aged 25-29 concentrations were similar but they increased in men until the age of 45-49, after which they showed no further increase; in women concentrations did not increase until the age of 40-44 and by the age of 50-59 values were higher than in men. Mean triglyceride concentrations were significantly higher in men than in women (1.8 (1.4) v 1.3 (0.9) mmol/l, respectively), and trends with age were similar to those for cholesterol concentrations, except that at no age were values higher in women than in men. Mean triglyceride values overall were higher in Glasgow and London than in Oxford and Leicester. Body mass index was higher in Glasgow and London than in the other two centres and correlated with systolic and diastolic blood pressures and triglyceride concentration. In addition, subjects in Glasgow smoked significantly more than those in the other centres. These observations could contribute to the higher rate of coronary heart disease in Glasgow. Plasma lipid concentrations and the prevalences of other risk factors for cardiovascular disease were similar in subjects selected by opportunistic case finding and by random selection. In Britain cholesterol values have changed little during the past 12 years despite dietary recommendations and health education.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135884      PMCID: PMC2546090          DOI: 10.1136/bmj.296.6638.1702

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  Lipoprotein fractionation by a precipitation method. A simple quantitative procedure.

Authors:  I C Onongbu; B Lewis
Journal:  Clin Chim Acta       Date:  1976-09-20       Impact factor: 3.786

2.  Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels.

Authors:  B Lewis; A Chait; I D Wootton; C M Oakley; D M Krikler; G Sigurdsson; A February; B Maurer; J Birkhead
Journal:  Lancet       Date:  1974-02-02       Impact factor: 79.321

3.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

Authors:  J Shepherd; D J Betteridge; P Durrington; M Laker; B Lewis; J Mann; J P Miller; J P Reckless; G R Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

4.  Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.

Authors:  G Heiss; I Tamir; C E Davis; H A Tyroler; B M Rifkand; G Schonfeld; D Jacobs; I D Frantz
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

5.  The marked decline in coronary heart disease mortality rates in the United States, 1968-1981; summary of findings and possible explanations.

Authors:  J Stamler
Journal:  Cardiology       Date:  1985       Impact factor: 1.869

6.  Heart disease prevention project: a randomised controlled trial in industry.

Authors:  G Rose; R F Heller; H T Pedoe; D G Christie
Journal:  Br Med J       Date:  1980-03-15

7.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

8.  Trends in coronary heart disease mortality and morbidity and related factors in Finland.

Authors:  K Pyörälä; J T Salonen; T Valkonen
Journal:  Cardiology       Date:  1985       Impact factor: 1.869

9.  Blood lipids in middle-aged British men.

Authors:  D S Thelle; A G Shaper; T P Whitehead; D G Bullock; D Ashby; I Patel
Journal:  Br Heart J       Date:  1983-03

10.  Smoking and other risk factors for coronary heart-disease in British civil servants.

Authors:  D D Reid; P J Hamilton; P McCartney; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

View more
  53 in total

Review 1.  Resource utilisation in the management of dyslipidaemia.

Authors:  T D Szucs
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

2.  Why heart disease mortality is low in France: the time lag explanation.

Authors:  M Law; N Wald
Journal:  BMJ       Date:  1999-05-29

3.  Choosing the preventive workload in general practice: practical application of the Coronary Prevention Group guidelines and Dundee coronary risk-disk.

Authors:  T Randall; J Muir; D Mant
Journal:  BMJ       Date:  1992-07-25

4.  Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. Imperial Cancer Research Fund OXCHECK Study Group.

Authors: 
Journal:  BMJ       Date:  1991-05-04

Review 5.  Best practice in primary care pathology: review 3.

Authors:  W S A Smellie; J Forth; D Bareford; P Twomey; M J Galloway; E C M Logan; S R S Smart; T M Reynolds; C Waine
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

6.  Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic disease.

Authors:  A F Winder; C Jagger; D P Garrick; D T Vallance; P F Butowski; J Anderson; M Clarke
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

Review 7.  Management of lipid disorders in the elderly.

Authors:  D A Playford; G F Watts
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

8.  Evaluation of a practice-based programme of health checks: financial cost and success at risk detection.

Authors:  G Sacks; R Marsden
Journal:  J R Coll Gen Pract       Date:  1989-09

9.  Serum lipid and apolipoprotein distributions in Hong Kong Chinese.

Authors:  P C Fong; S C Tam; Y T Tai; C P Lau; J Lee; Y Y Sha
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

10.  Florid xanthelasmata (yellow lids) in orbital Wegener's granulomatosis.

Authors:  A B Tullo; P Durrington; E Graham; L P Holt; D L Easty; R Bonshek; J L Noble
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.